<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2025.1657524</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>
<italic>Akkermansia muciniphila</italic> alleviates cognitive impairment and neuroinflammation induced by blunt chest trauma</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Liu</surname>
<given-names>Lin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Wang</surname>
<given-names>Linxiao</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2931423/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Yanjun</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Heping</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gao</surname>
<given-names>Xi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Yin</surname>
<given-names>Wen</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Xie</surname>
<given-names>Jiangang</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2719996/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Emergency, Honghui Hospital, School of Medicine, Xi&#x2019;an Jiao Tong University</institution>, <addr-line>Shaanxi, Xi&#x2019;an</addr-line>,&#xa0;<country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Emergency, First Affiliated Hospital of Air Force Medical University</institution>, <addr-line>Shaanxi, Xi&#x2019;an</addr-line>,&#xa0;<country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Clinical Laboratory, Honghui Hospital, School of Medicine, Xi&#x2019;an Jiao Tong University</institution>, <addr-line>Shaanxi, Xi&#x2019;an</addr-line>,&#xa0;<country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Interventional Vascular, Xi&#x2019;an No.3 Hospital, Affiliated Hospital of Northwest University</institution>, <addr-line>Shaanxi, Xi&#x2019;an</addr-line>,&#xa0;<country>China</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Xi&#x2019;an Key Laboratory of Metabolic Disease Imaging, Xi&#x2019;an No.3 Hospital, Affiliated Hospital of Northwest University</institution>, <addr-line>Xi&#x2019;an</addr-line>,&#xa0;<country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Am&#xe9;lia M. Sarmento, Fernando Pessoa University, Portugal</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/709546/overview">Anup Bhusal</ext-link>, Kyungpook National University, Republic of Korea</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/748737/overview">Zhenyu Yin</ext-link>, Tianjin Medical University General Hospital, China</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Jiangang Xie, <email xlink:href="mailto:william@fmmu.edu.cn">william@fmmu.edu.cn</email>; Wen Yin, <email xlink:href="mailto:xjyyyw@fmmu.edu.cn">xjyyyw@fmmu.edu.cn</email>
</p>
</fn>
<fn fn-type="equal" id="fn003">
<p>&#x2020;These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>01</day>
<month>10</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>16</volume>
<elocation-id>1657524</elocation-id>
<history>
<date date-type="received">
<day>01</day>
<month>07</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>09</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Liu, Wang, Wang, Zhao, Gao, Yin and Xie.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Liu, Wang, Wang, Zhao, Gao, Yin and Xie</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>Blunt chest trauma, commonly caused by traffic accidents, falls, and violent incidents, results in both direct mechanical injury to the thoracic cavity&#x2014;leading to increased intrathoracic pressure and vascular rupture&#x2014;and indirect effects on the central nervous system (CNS), causing extensive damage that severely impacts patient health and quality of life. Akkermansia muciniphila (AKK), a probiotic bacterium inhabiting the gut mucus layer, modulates gut microbiota and metabolites, with potential therapeutic effects on various neurological disorders through the gut-brain axis.</p>
</sec>
<sec>
<title>Methods</title>
<p>Mice were divided into four groups: control, trauma, trauma+PBS, and trauma+AKK. AKK bacterial suspension was administered <italic>via</italic> gavage for three weeks. Behavioral tests including the OFT, EPM, NORT, and Y-maze were conducted to assess anxiety-like behaviors and cognitive function. Neuroinflammatory markers in the hippocampus were measured using qPCR, immunofluorescence, and Western blot. Gut microbiota and metabolites were analyzed through 16S rRNA sequencing and metabolomics.</p>
</sec>
<sec>
<title>Results</title>
<p>Mice subjected to blunt chest trauma displayed emotional abnormalities and cognitive deficits. AKK treatment significantly alleviated anxiety-like behaviors and improved cognitive function, reduced pro-inflammatory cytokine levels in the hippocampus, and reshaped gut microbiota composition. AKK also modulated the expression of metabolites linked to neuroinflammation and cognitive function, upregulated BDNF and TrkB, and decreased IBA1, suggesting it enhances cognitive function by modulating neuroinflammation and the BDNF/TrkB signaling pathway.</p>
</sec>
<sec>
<title>Conclusions</title>
<p>AKK mitigates cognitive impairment and neuroinflammation after blunt chest trauma by modulating gut microbiota and metabolites. Targeting the gut-brain axis may offer new strategies for preventing and treating trauma-induced neurological disorders.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Akkermansia muciniphila</kwd>
<kwd>blunt chest trauma</kwd>
<kwd>cognitive function</kwd>
<kwd>neuroinflammation</kwd>
<kwd>microglia</kwd>
<kwd>BDNF</kwd>
</kwd-group>
<counts>
<fig-count count="9"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="64"/>
<page-count count="18"/>
<word-count count="7164"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Microbial Immunology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Unintentional injuries and accidents rank as the leading cause of death in individuals under 45 years of age and the third leading cause of mortality overall (<xref ref-type="bibr" rid="B1">1</xref>). Approximately 25% of trauma-related deaths are attributed to chest injuries or their complications (<xref ref-type="bibr" rid="B2">2</xref>), with blunt chest trauma comprising 70% of such cases (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>). This form of trauma can cause a rapid rise in intrathoracic pressure, rupture of critical blood vessels such as the thoracic aorta, and life-threatening conditions like airway obstruction, pneumothorax, and hemothorax (<xref ref-type="bibr" rid="B5">5</xref>). Furthermore, hemodynamic changes resulting from blunt chest trauma can impair cerebral blood flow, leading to brain tissue hypoxia (<xref ref-type="bibr" rid="B6">6</xref>). Chest injuries also activate the sympathetic nervous system, triggering a systemic stress response that increases blood pressure and heart rate, exacerbating cerebral hypoxia. Simultaneously, immune activation releases inflammatory cells and cytokines into the bloodstream, which can cross the blood-brain barrier, enter the CNS, and induce neuroinflammation, causing neuronal damage (<xref ref-type="bibr" rid="B7">7</xref>). Approximately 50% of patients with blunt chest trauma experience persistent pain, which can lead to neuroinflammation and cognitive deficits, such as memory impairment and diminished cognitive function (<xref ref-type="bibr" rid="B8">8</xref>). Current treatments for acute chest trauma primarily emphasize early mobilization and respiratory support, while post-traumatic neuropathic pain remains underdiagnosed (<xref ref-type="bibr" rid="B9">9</xref>). Secondary neurological damage following blunt chest trauma significantly impacts long-term prognosis.</p>
<p>Blunt chest trauma also activates both sympathetic and parasympathetic pathways, leading to gastrointestinal dysfunction, including reduced motility, vasoconstriction, and gut microbiota dysbiosis. This imbalance can produce toxins and metabolites that activate the immune system <italic>via</italic> the gut-brain axis, influencing CNS function and inducing neuroinflammation and neurodegeneration, which impair cognitive function (<xref ref-type="bibr" rid="B10">10</xref>). Numerous studies have demonstrated that modulating the composition and abundance of gut microbiota can influence immune responses and CNS function by altering the release of neuroactive substances, metabolites, and hormones (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B12">12</xref>). Li et&#xa0;al. showed that inhibiting LPS-induced gut microbiota alterations in mice improves cognitive dysfunction (<xref ref-type="bibr" rid="B13">13</xref>). Wang et&#xa0;al., through Mendelian randomization analysis, found that gut microbiota-targeted interventions can enhance cognitive function (<xref ref-type="bibr" rid="B14">14</xref>). Thus, modulating the gut-brain axis represents a promising strategy for mitigating neurological disorders following blunt chest trauma.</p>
<p>
<italic>Akkermansia muciniphila</italic> (AKK) is a probiotic bacterium that resides in the outer mucus layer of the gastrointestinal tract. It plays a critical role in maintaining gut barrier integrity and regulating host metabolism, including glucose and lipid metabolism, inflammatory responses, and gut barrier function (<xref ref-type="bibr" rid="B15">15</xref>&#x2013;<xref ref-type="bibr" rid="B17">17</xref>). Increasing evidence highlights a strong correlation between AKK abundance and behaviors related to emotion and learning, particularly in the context of gut microbiota reshaping (<xref ref-type="bibr" rid="B18">18</xref>&#x2013;<xref ref-type="bibr" rid="B20">20</xref>). AKK has been shown to reduce inflammatory markers and regulate gut metabolites, such as short-chain fatty acids (SCFAs) and neurotransmitters, which influence cognitive function (<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B22">22</xref>). However, the mechanisms through which AKK modulates the microbiota-gut-brain axis and improves neurological function in trauma-induced neurological disorders remain poorly understood.</p>
<p>This study aims to investigate the impact of AKK supplementation on neurological function in a mouse model of blunt chest trauma while exploring the underlying mechanisms involved. Pathological changes and neuroinflammation in the hippocampus following AKK supplementation were assessed, and microbiome and metabolomics techniques were employed to identify the potential pathways through which AKK modulates neurological disorders induced by blunt chest trauma. The findings from this study offer insights into potential therapeutic targets for preventing and treating neurological disorders following blunt trauma.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="s2_1">
<title>Reagents</title>
<p>
<italic>Akkermansia muciniphila</italic> (AKK, ATCC BAA-835) was obtained from Mingzhou Bio (China). Reagents for RNA reverse transcription to cDNA (Cat# 11141ES10, Yeasen) and SYBR Green (Cat# 11201ES08, Yeasen) were utilized. Western blot antibodies included IBA1 (#A30311, Nature Biosciences), pTrkB (#A46276, Nature Biosciences), TrkB (#ab108319, Cell Signaling Technology), BDNF (#A50292, Nature Biosciences), ERK1/2 (#9102, Cell Signaling Technology), pERK1/2 (#9101, Cell Signaling Technology), CREB (#9197, Cell Signaling Technology), pCREB (#9198, Cell Signaling Technology), and &#x3b2;-actin (#4967, Cell Signaling Technology).</p>
</sec>
<sec id="s2_2">
<title>Animals</title>
<p>Sixty male C57BL/6J mice (Charles River, Germany), weighing 23 &#xb1; 3g, were used. All mice were acclimated for 14 days prior to treatment and were age-matched (approximately 10 weeks old). The animals were housed in a controlled environment (21 &#xb1; 2&#xb0;C, 50% relative humidity) with ad libitum access to food and water. Only male C57BL/6J mice were used in this preliminary study due to sex-related differences in hormonal and immune responses (<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B24">24</xref>). The study was approved by the Health Science Center of XJTU Approval for Research Involving Animals (approval number: XJTYAE2024-1396).</p>
</sec>
<sec id="s2_3">
<title>Group distribution and experimental procedures</title>
<p>Mice were randomly assigned to one of four groups: Control (no treatment), Trauma, Trauma+PBS (100 &#xb5;L sterile PBS daily), and Trauma+AKK (100 &#xb5;L AKK bacterial suspension at 2 &#xd7; 10<sup>9</sup> CFU/mL daily). The AKK suspension was administered <italic>via</italic> gavage for three weeks.</p>
</sec>
<sec id="s2_4">
<title>Blunt thoracic trauma</title>
<p>Blunt chest trauma was induced as previously described. Oxygen was turned on and the flow rate was adjusted to 0.25 MPa, 1 L/min. The concentration of the anesthetic (isoflurane) was set to 5%, and induction anesthesia was completed in approximately 1 minute. Subsequently, the anesthetic concentration was adjusted to 2%, and a mouse mask was connected for continuous inhalation. Mice were anesthetized with isoflurane gas, and a cylindrical weight (50 &#xb1; 2g) was dropped from a height of 300 &#xb1; 2mm onto a platform placed on the chest. The impact energy (E) was calculated using the formula E = m &#xd7; g &#xd7; h, where m is the weight (kg), g is the acceleration due to gravity (9.8 m/s<sup>2</sup>), and h is the height (m) (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B26">26</xref>). Preliminary experiments indicated that a 300mm height and 50g weight (E=0.15 J) induced blunt chest trauma without causing severe complications, such as pneumothorax, hemothorax, cardiac rupture, or immediate death. Following impact, mice exhibited transient shock and rapid breathing and regained motor function after anesthesia recovery. To mitigate behavioral abnormalities caused by pain in surviving mice post-trauma, we administered meloxicam <italic>via</italic> subcutaneous injection at a dose of 5 mg/kg, with daily dosing for 3 days post-surgery. Additionally, we allowed sufficient time for the mice to recover from the acute pain phase post-surgery (<xref ref-type="bibr" rid="B27">27</xref>). To assess the consistency of pain in the mice, we monitored their pain behavior by observing the distance traveled in the open field test. There was no significant difference in the total distance traveled in the open field between trauma-induced mice and normal mice, after which we further assessed the emotional behavior of the mice.</p>
</sec>
<sec id="s2_5">
<title>Open field test</title>
<p>Mice were acclimated to the testing environment for 1 hour prior to behavioral testing to minimize external interference. The testing arena (50cm &#xd7; 50cm &#xd7; 40cm) was cleaned with 75% ethanol between each test to remove residual odors. Mice were placed in the center of the arena and allowed to explore for 10 minutes. Behavioral recordings included trajectory, distance traveled, time spent, and speed, which were analyzed using Noldus EthoVision software. Reduced inner area activity and shorter exploration times were indicative of anxiety-like behavior (<xref ref-type="bibr" rid="B28">28</xref>).</p>
</sec>
<sec id="s2_6">
<title>Elevated plus-maze test</title>
<p>Mice were acclimated to the testing environment for at least 1 hour prior to the test. The apparatus was cleaned between each test to ensure a scent-free environment. Mice were placed in the center of the maze facing an open arm and allowed to explore for 5 minutes. Behavior was recorded, and trajectories, distance traveled, entries into the open arms, and time spent in the open arms were analyzed using Noldus EthoVision software. Reduced activity in the open arms, indicated by shorter distances and times, was interpreted as anxiety-like behavior (<xref ref-type="bibr" rid="B29">29</xref>).</p>
</sec>
<sec id="s2_7">
<title>Tail suspension test</title>
<p>The posterior third of the mouse tail was suspended from a support, with the head positioned 15cm above the table. Behavior was recorded for 5 minutes, and immobility time was analyzed using Smart v3.0 software. Increased immobility time suggested depression-like behavior (<xref ref-type="bibr" rid="B30">30</xref>).</p>
</sec>
<sec id="s2_8">
<title>Forced swimming test</title>
<p>Mice were placed in a transparent cylinder (10cm diameter &#xd7; 18cm height) filled with water (2/3 volume at 25 &#xb0;C) for 6 minutes. Behavior was recorded during the final 5 minutes, and immobility time was analyzed using the software. Extended immobility times were indicative of depression-like behavior (<xref ref-type="bibr" rid="B30">30</xref>).</p>
</sec>
<sec id="s2_9">
<title>Novel object recognition test</title>
<p>The test consisted of three phases: habituation, training, and testing. During the habituation phase, mice explored an open field for 10 minutes on the first day. On the training day, mice were exposed to two identical objects for 10 minutes. In the testing phase, mice were presented with a familiar object (A1) and a novel object (A2) for 10 minutes. Exploration was defined as touching or directing the head within 2cm of the object. All objects and the arena were cleaned with 75% ethanol between tests. The preference index was calculated as the time spent exploring the novel object (T<sub>A2</sub>) divided by the total exploration time for both objects (T<sub>A1</sub> + T<sub>A2</sub>). Normal cognitive function was indicated by a preference for the novel object (<xref ref-type="bibr" rid="B29">29</xref>).</p>
</sec>
<sec id="s2_10">
<title>Y-maze</title>
<p>The Y-maze test also involved three phases: habituation, training, and testing. During the habituation phase, mice were food-deprived for one day but had free access to water. Food was placed in all three arms of the Y-maze, and mice were allowed to explore for 10 minutes twice a day over two days. During training, mice were food-deprived for one day, with food placed in one arm (the food arm) and the other two arms left empty. Mice explored for 10 minutes twice a day for two to three days. In the test phase, mice were food-deprived for one day, and all three arms were empty. Mice were placed in the start arm (the non-food arm), and the number of entries and time spent in the food arm were recorded. Time spent in the food arm indicated learning and memory ability, with longer times suggesting better memory. Longer times spent in the error arm (other than the start or food arms) indicated poorer memory (<xref ref-type="bibr" rid="B31">31</xref>).</p>
</sec>
<sec id="s2_11">
<title>Pathological staining</title>
<p>Hematoxylin-Eosin (HE) Staining: Tissue was fixed at room temperature for 24 hours, dehydrated, embedded in paraffin, and sectioned at 4 &#xb5;m thickness. Sections were stained with hematoxylin and eosin and observed under a microscope.</p>
<p>Immunofluorescence (IF) Staining: Tissue sections were dewaxed, rehydrated, and subjected to antigen retrieval using citrate buffer. Endogenous peroxidase activity was blocked with 3% H<sub>2</sub>O<sub>2</sub>. Sections were incubated with primary antibodies overnight at 4&#xb0;C, followed by incubation with secondary antibodies for 1 hour at room temperature. Sections were mounted with an anti-fade mounting medium and observed under a fluorescence microscope. Fluorescence intensity was quantified using ImageJ software.</p>
</sec>
<sec id="s2_12">
<title>Gut microbiota 16S sequencing</title>
<p>16S rRNA gene sequencing was employed to analyze the gut microbiota of traumatized mice. The V3-V4 regions of the 16S rDNA were amplified <italic>via</italic> PCR, purified on a 2% agarose gel, and quantified. The fragments were sequenced on the Illumina platform following the manufacturer&#x2019;s paired-end read protocol (PE250). Representative sequences for each operational taxonomic unit (OTU) were classified using the RDP Classifier software with a Bayesian algorithm at a confidence level of 0.8. Bioinformatics analysis was performed using the Omicsmart platform.</p>
</sec>
<sec id="s2_13">
<title>Metabolomics sequencing</title>
<p>Metabolomic analysis was performed using an Agilent 1290 Infinity LC system coupled with an AB Triple TOF 6600 mass spectrometer. Chromatographic separation was achieved on an HSS T3 column. For positive electrospray ionization (ESI) mode, the mobile phase consisted of water with 0.1% formic acid (solvent A) and acetonitrile (solvent B). For negative ESI mode, water containing 0.5 mM ammonium formate (solvent A) and acetonitrile (solvent B) was used. Bioinformatics analysis was performed to identify potential metabolites.</p>
</sec>
<sec id="s2_14">
<title>Quantitative real-time polymerase chain reaction</title>
<p>Total RNA was isolated using a Trizol reagent, and RNA concentration was measured. RNA was reverse-transcribed into cDNA according to the manufacturer&#x2019;s instructions. For qPCR reactions, cDNA, gene-specific primers, and SYBR Green were mixed. Primer sequences are provided in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1</bold>
</xref>.</p>
</sec>
<sec id="s2_15">
<title>Western blot</title>
<p>Total protein was extracted from tissues using RIPA lysis buffer, and protein concentration was measured using a BCA assay kit. Proteins were separated by SDS-PAGE and transferred to PVDF membranes. Membranes were incubated with primary antibodies and HRP-conjugated secondary antibodies. Protein bands were visualized using a ChemiDoc imaging system (Bio-Rad, Hercules, CA, USA), and band intensity was analyzed using ImageJ software.</p>
</sec>
<sec id="s2_16">
<title>Statistical analysis</title>
<p>The study adhered to principles of randomization and blinding to ensure objectivity. Results are presented as mean &#xb1; standard error (SEM). Statistical analysis was conducted using unpaired t-tests, Welch&#x2019;s t-tests, or one-way ANOVA with GraphPad Prism version 8. <italic>P</italic>-values less than 0.05 were considered statistically significant.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>Reproducibility and survival rate of the blunt thoracic trauma mouse model</title>
<p>Regarding the reproducibility of the blunt chest trauma mouse model, the survival rate of the mice was 69% (with 12 deaths and 27 survivals). Mice that died following trauma either succumbed immediately or within 24 hours post-trauma. Upon autopsy, these deceased mice exhibited substantial hemorrhaging within the thoracic cavity, perforation or rupture of the right atrium, yet no rib fractures or visible damage to abdominal organs were observed. Surviving mice displayed transient respiratory depression immediately after injury, subsequently presenting with rapid breathing, piloerection, lethargy, and reduced activity. These symptoms gradually normalized by day 3 post-trauma. We harvested tissues from mice 3 days post-trauma and observed contusions on the left and right lungs caused by the ribs. Histological examination of the heart and lung tissues of the trauma-induced mice <italic>via</italic> HE staining revealed extensive pulmonary hemorrhage and edema, with alveoli infiltrated by a large number of inflammatory cells and thickened alveolar septa. In contrast, normal mouse lung tissue exhibited intact alveolar structures with thin and uniform alveolar walls. As for the heart, trauma-induced mice showed unclear myocardial striations, disordered arrangement, vacuolization of myocardial cells, and blurred cell boundaries, while normal mouse heart tissue had neatly arranged myocardial fibers with clear structures (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1</bold>
</xref>). These findings indicate that we have successfully induced blunt chest trauma in mice.</p>
</sec>
<sec id="s3_2">
<title>Cognitive impairment and anxiety induced by trauma</title>
<p>To evaluate the effects of trauma on cognitive and emotional behaviors in mice, behavioral tests were conducted to assess learning and memory, anxiety, and depression. In the OFT, the total distance traveled by traumatized mice did not significantly differ from that of controls (<italic>P</italic> &gt; 0.05, <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>), suggesting no substantial impact on overall motor function. However, from day 14 to day 60 post-trauma, traumatized mice exhibited significantly reduced distances and time spent in the inner area compared to controls (<italic>P</italic>&lt;0.05, <xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1B, C</bold>
</xref>). In the NORT, traumatized mice showed significantly decreased exploration times and frequencies for the novel object starting at day 14 (<italic>P</italic>&lt;0.05, <xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1D, E</bold>
</xref>), with a lower preference index (<italic>P</italic>&lt;0.05, <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1F</bold>
</xref>) that persisted through day 60. By day 60, however, the frequency of novel object exploration did not significantly differ from controls, indicating partial recovery of interest in novel objects. In the TST and FST, traumatized mice showed no significant differences in immobility times compared to controls (<italic>P</italic> &gt; 0.05, <xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1G, H</bold>
</xref>). Overall, while traumatized mice exhibited anxiety and cognitive impairments from day 14 onward, no depression-like behaviors were observed.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Cognitive and behavioral impairments in trauma-exposed mice. <bold>(A-C)</bold> Results of the OFT at different time points. <bold>(A)</bold> Total distance traveled by the mice in the open area. <bold>(B)</bold> Distance traveled in the inner area. <bold>(C)</bold> Time spent in the inner area. <bold>(D-F)</bold> Results of the novel object recognition test at various time points. <bold>(D)</bold> Total distance traveled by the mice. <bold>(E)</bold> Number of touches to the novel object. <bold>(F)</bold> Preference index [A2/(A1+A2)]. <bold>(G, H)</bold> Depression-like behaviors in the forced swimming test (FST) and tail suspension test (TST), with no significant differences observed. Data are presented as mean &#xb1; SEM. n = 6, *<italic>P</italic> &lt;&#x2009;0.05, **<italic>P</italic>&lt;0.01, ***<italic>P</italic>&lt; 0.001, ns, no statistical significance vs. control.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1657524-g001.tif">
<alt-text content-type="machine-generated">Bar charts display behavioral data comparing control and trauma groups across multiple time points: baseline, fourteen days, twenty-eight days, and sixty days. Graphs A to H measure total distance, distance in inner areas, time in inner areas, time with novel objects, number of contacts, preference index, forced swim test duration, and tail suspension test duration. Statistical significance is indicated with asterisks, showing varying differences between groups over time, with a legend identifying control and trauma groups.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_3">
<title>Gut microbiota dysbiosis induced by trauma</title>
<p>To explore the impact of trauma on gut microbiota, the relative abundance of fecal microbiota at the genus level was analyzed using 16S rRNA sequencing 14 days post-trauma. Traumatized mice exhibited significant increases in the relative abundance of <italic>Lactobacillus</italic>, <italic>Mycoplasma</italic>, <italic>Allobaculum</italic>, and <italic>Bacteroides</italic> compared to controls (<italic>P</italic>&lt;0.05). In contrast, <italic>Lachnospiraceae NK4A136 group</italic>, <italic>Akkermansia</italic>, and <italic>Dubosiella</italic> were significantly decreased (<italic>P</italic>&lt;0.05), while Parasutterella remained unchanged (<italic>P</italic> &gt; 0.05, <xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>). Akk, a member of the genus <italic>Akkermansia</italic>, has been shown to restore gut microbiota balance and regulate brain function (<xref ref-type="bibr" rid="B32">32</xref>). However, whether AKK can modulate trauma-induced gut microbiota dysbiosis and cognitive impairments remains unclear.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Trauma induces intestinal microbiota disruption in mice. Relative abundance of intestinal bacterial species, including <italic>Lactobacillus</italic>, <italic>Lachnospiraceae NK4A136 group</italic>, <italic>Akkermansia</italic>, <italic>Mycoplasma</italic>, <italic>Dubosiella</italic>, <italic>Allobaculum</italic>, <italic>Bacteroides</italic>, and <italic>Parasutterella</italic>, was assessed by 16S rRNA sequencing 14 days post-trauma, n = 7. *<italic>P</italic> &lt; 0.05, **<italic>P</italic>&lt; 0.01, ***<italic>P</italic>&lt; 0.001, ns = no statistical significance vs. control.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1657524-g002.tif">
<alt-text content-type="machine-generated">Bar charts comparing the relative abundance of various bacteria in control and trauma groups. Significant differences are marked by asterisks, with Lactobacillus showing a higher abundance in trauma, while Lachnospiraceae, Akkermansia, Dubosiella, and Bacteroides are higher in controls. Mycoplasma and Allobaculum are more abundant in trauma. Parasutterella shows no significant difference.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_4">
<title>AKK treatment improves cognitive impairment and anxiety in traumatized mice</title>
<p>To investigate whether AKK treatment could alleviate behavioral abnormalities in traumatized mice, this study administered AKK and assessed behavioral changes (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>). In the OFT, AKK-treated traumatized mice (Trauma+AKK) showed no significant difference in total distance traveled compared to Trauma+PBS. However, they exhibited significantly increased distances and time spent in the inner area (<italic>P</italic>&lt;0.05, <xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>). In the EPM test, traumatized mice had reduced exploration times and entries into the open arms compared to controls. AKK treatment significantly increased these parameters in traumatized mice (<italic>P</italic>&lt;0.05, <xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>). In the NORT, AKK-treated traumatized mice showed no significant difference in total distance traveled, but had significantly increased exploration frequencies and preference indices for the novel object (<italic>P</italic>&lt;0.05, <xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3D</bold>
</xref>). In the Y-maze test, the number of entries and the time spent in the wrong arm were significantly increased in the trauma-induced mice compared with the control group (<italic>P &lt;</italic>0.001, <xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3E</bold>
</xref>). However, AKK treatment significantly reduced the number of entries and the time spent in the wrong arm in the trauma-induced mice compared with the Trauma + PBS group (<italic>P &lt;</italic>0.05, <xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3E</bold>
</xref>). AKK treatment significantly improved cognitive function-related parameters. Overall, AKK treatment significantly improved anxiety-like behaviors and cognitive impairments in traumatized mice.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>AKK treatment ameliorates cognitive dysfunction in trauma-exposed mice. <bold>(A)</bold> Behavioral testing timeline and treatment schedule for probiotic administration. <bold>(B)</bold> Behavior trajectory and heatmap from the OFT, divided into 16 sections, with the central 4 sections (highlighted in yellow) representing the inner area. The total distance (cm) in the open field, including the distance traveled in the inner area (cm) and time spent in the inner area (s), are also shown. <bold>(C)</bold> Behavior trajectory and heatmap from the EPM (yellow for the open arms, blue for the closed arms), with the total distance (cm) calculated. Entries into the open arms and time spent in the open arms (s) are also displayed. <bold>(D)</bold> Behavior trajectory and heatmap from the novel object recognition test (yellow for the novel object A2, blue for the familiar object A1), with the total distance (cm) calculated. The number of contacts with the objects and the preference index [T<sub>A2</sub>/(T<sub>A1</sub>+T<sub>A2</sub>)] are shown. <bold>(E)</bold> Behavior trajectory and heatmap from the Y-maze test (green for the food arm, yellow for the error arm, and blue for the start arm). The total distance (cm), percent entries in the wrong arm, and time in the wrong arm are also indicated. n &#x2265; 6, *<italic>P</italic> &lt;&#x2009;0.05, **<italic>P</italic>&lt;0.01, ***<italic>P</italic>&lt;0.001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1657524-g003.tif">
<alt-text content-type="machine-generated">Experimental timeline and results for behavioral tests are presented. Section A shows the schedule for treatment, trauma exposure, and testing days. Sections B to E display trajectory and heatmap data, alongside bar graphs for four different conditions: Control, Trauma, Trauma plus PBS, and Trauma plus AKK. Bar graphs in each section highlight metrics like total distance, time in specific areas, and entries. Statistical significance is denoted with asterisks. The layout provides visual and quantitative comparisons between conditions.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_5">
<title>AKK treatment restores gut microbiota dysbiosis</title>
<p>Growing evidence indicates that gut microbiota influences brain function and cognitive performance through the gut-brain axis, primarily <italic>via</italic> metabolites and neurotransmitters (<xref ref-type="bibr" rid="B33">33</xref>). Dysbiosis can disrupt intestinal permeability, allowing bacteria and toxins to enter the bloodstream, thereby inducing inflammation that impairs cognitive and emotional functions. To explore whether AKK treatment modulates trauma-induced changes in gut microbiota, 16S rDNA sequencing was performed to assess microbial composition and abundance in traumatized mice. Fourteen samples from two groups (n = 7 per group) were sequenced to generate V3-V4 16S rRNA gene profiles. Beta-diversity was evaluated using PCA, PCoA, and NMDS to determine microbial community similarity. PCA revealed distinct group separation (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>, left), with principal components PC1 and PC2 accounting for 59.76% and 15.39% of the variation, respectively. PCoA showed that PC1 and PC2 explained 42.85% and 15.56% of the variation (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>, middle). NMDS analysis, with stress = 0.033 (stress &lt; 0.05), confirmed significant differences between samples (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>, right). AKK treatment was found to significantly alter the gut microbiota composition, with increases in <italic>Lactobacillus</italic> and <italic>Akkermansia</italic> at the family, genus, and species levels, while <italic>Bacteroides</italic> decreased (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>). To pinpoint bacterial taxa linked to AKK treatment in traumatized mice, Welch&#x2019;s t-tests identified the top 10 core taxa explaining group differences. As shown in <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4C</bold>
</xref>, AKK-treated traumatized mice (vs. Trauma+PBS) exhibited lower levels of <italic>Bacteroides sartorii</italic> (<italic>P</italic>=0.004), <italic>Bacteroides acidifaciens</italic> (<italic>P</italic>=0.004), and <italic>Muribaculum intestinale</italic> (<italic>P</italic>=0.046), while <italic>Akkermansia muciniphila</italic> (<italic>P</italic>=0.017) and <italic>Lactobacillus murinus</italic> (<italic>P</italic>=0.001) increased significantly. A heatmap of the top 20 species at the family level is provided in <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4D</bold>
</xref>. Functional abundance heatmaps indicated associations with carbohydrate metabolism, amino acid metabolism, cofactor and vitamin metabolism, terpenoid and polyketone metabolism, other amino acid metabolism, and lipid metabolism (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4E</bold>
</xref>). Further functional predictions using PICRUSt2 revealed that trauma altered various biological processes in gut microbiota, particularly metabolism, genetic information processing, and cellular processes.</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Gut microbiota 16S rRNA sequencing in traumatized mice. <bold>(A)</bold> &#x3b2;-diversity analysis of samples from the two groups, using PCA, PCoA, and NMDS. <bold>(B)</bold> Distribution stacked map for family, genus, and species. <bold>(C)</bold> Comparison of genus-level differences between the two groups, with Welch&#x2019;s t-tests performed on the top 10 species showing statistical significance. <bold>(D)</bold> Family-level distribution heatmap, with &#x201c;P&#x201d; representing Trauma+PBS and &#x201c;A&#x201d; representing Trauma+AKK. <bold>(E)</bold> Stacked diagram of functional categories at Level 2 of the KEGG database. <bold>(F)</bold> PICRUSt2 Functional Distribution General Map. &#x201c;Trauma P&#x201d; represents Trauma+PBS, and &#x201c;Trauma A&#x201d; represents Trauma+AKK.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1657524-g004.tif">
<alt-text content-type="machine-generated">Composite image showcasing gut microbiota analysis in trauma patients. Panel A shows PCA, PCoA, and NMDS plots differentiating Trauma_P and Trauma_A groups. Panel B presents bar charts of relative abundance by family, genus, and species. Panel C illustrates mean abundance and confidence intervals for specific bacteria. Panel D displays a heatmap of bacterial families across samples. Panel E shows relative abundance of metabolic pathways. Panel F provides detailed abundance data on various metabolic and genetic information processing functions.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_6">
<title>AKK treatment modulates metabolite composition in traumatized mice</title>
<p>Given the ability of gut microbiota to influence the host through metabolites, metabolomics analysis was conducted on traumatized mice. OPLS-DA modeling (T score = 14.9%) and permutation tests confirmed the model&#x2019;s reliability and predictability (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>). Bar and volcano plots displayed upregulated and downregulated metabolites based on statistical thresholds (<italic>P</italic>&lt;0.05, |log2FC| &gt; 1, <xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5B</bold>
</xref>). AKK treatment in traumatized mice (vs. Trauma+PBS) revealed 70 differential metabolites, with 29 upregulated and 41 downregulated. A heatmap illustrating the top 20 most differentially expressed metabolites between groups was also constructed (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5C</bold>
</xref>). Variable Importance in Projection (VIP) analysis identified key metabolites, such as a significant decrease in 2,4-diaminobenzenesulfonic acid and 3-methyl-2-oxopentanoate, and an increase in chelidonic acid, 1-stearoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine, and 4,5-dihydro-4,5-dioxo-1h-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid in AKK-treated traumatized mice (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5D</bold>
</xref>). KEGG enrichment analysis indicated that these differential metabolites were involved in alanine metabolism, alanine, aspartate, and glutamate metabolism, oxidative phosphorylation, histidine biosynthesis, purine-derived alkaloid biosynthesis, ABC transporters, and other biological processes (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5E</bold>
</xref>).</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Serum metabolite sequencing in traumatized mice. <bold>(A)</bold> OPLS-DA score plot and permutation test plot comparing the groups. <bold>(B)</bold> Bar chart and volcano plot of differential gene expression. <bold>(C)</bold> Cluster heatmap of differential metabolite expression between the two groups, with &#x201c;<italic>P</italic>&#x201d; indicating Trauma+PBS and &#x201c;A&#x201d; representing Trauma+AKK. <bold>(D)</bold> Variable Importance in Projection (VIP) plot for differential metabolite expression between the two groups. <bold>(E)</bold> KEGG functional enrichment analysis of differentially expressed metabolites.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1657524-g005.tif">
<alt-text content-type="machine-generated">Data visualization with multiple panels:   A) Two plots showing a statistical analysis; left is a scatter plot with ellipses; right shows scatter points with a trend line, indicating R-squared and Q-squared values.  B) Bar chart and volcano plot; bar chart shows upregulated and downregulated features, and volcano plot highlights points by VIP score with significance noted.  C) Heatmap visualizing metabolite levels across samples, with colors representing concentration levels.  D) Bar chart visualizing metabolites by treatment group, colored to indicate concentration levels.  E) Bubble plot titled &#x201c;Top 15 of KEGG Enrichment,&#x201d; showing pathways with metabolite ratios and significance.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_7">
<title>Correlation analysis between metabolites and gut microbiota</title>
<p>Subsequently, the correlation between gut microbiota and metabolites was explored. The O2PLS model loading plot (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6A</bold>
</xref>) demonstrated a strong association between the microbiota and metabolites. Further genus-level heatmap analysis revealed specific correlations between microbiota and metabolites. For example, <italic>Escherichia-Shigella</italic> exhibited a positive correlation with gamma- muricholic acid, 19(r)-hydroxyprostaglandin, coumaphos-o-analog, phosphocholine, and quinclorac, but a negative correlation with isopentedrone. <italic>Odoribacter</italic> showed a positive correlation with D-ribulose 1,5-bisphosphate but a negative correlation with DL-tryptophan (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6B</bold>
</xref>).</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Correlation analysis between metabolites and gut microbiota. <bold>(A)</bold> O2PLS model illustrating the association between species and metabolites at the genus level. <bold>(B)</bold> Pearson correlation heatmap of metabolites and gut microbiota at the genus level. *<italic>P</italic> &lt;&#x2009;0.05, **<italic>P</italic>&lt;0.01, ***<italic>P</italic>&lt;0.001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1657524-g006.tif">
<alt-text content-type="machine-generated">Chart A shows a scatter plot of top joint loadings with 'microbe' data in orange and 'metabolite' in blue. Plot axes are labeled with first and second joint loadings. Chart B is a heatmap with different chemicals and substances listed, showing color gradients from red to blue, indicating varying levels of correlation or data value, with a scale from minus 0.5 to plus 0.5.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_8">
<title>AKK treatment alleviates neuroinflammation in traumatized mice</title>
<p>To evaluate the neuroprotective effects of AKK, neuroinflammation in the hippocampus of traumatized mice was assessed through HE staining and cytokine expression analysis. The hippocampus, a key region in the limbic system, comprises the Cornu Ammonis (CA) 1, CA2, CA3, CA4, and Dentate Gyrus (DG), all of which are integral to memory formation, emotional regulation, and cognitive function. HE staining revealed that traumatized mice (vs. Control) displayed sparsely and disordered pyramidal neurons arrangement in the CA1 region, along with neuronal nuclear condensation and necrosis in the CA3 and DG regions. AKK treatment, however, significantly alleviated these pathological alterations in the hippocampus (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7A</bold>
</xref>). QPCR analysis indicated significantly increased levels of pro-inflammatory cytokines (<italic>Il1&#x3b2;</italic>, <italic>Il6</italic>, <italic>Il12</italic>, <italic>Tnf&#x3b1;</italic>) and decreased expression of the anti-inflammatory cytokine <italic>Il10</italic> and <italic>Tgf&#x3b2;</italic> in the hippocampus of traumatized mice (<italic>P</italic>&lt;0.05, <xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7B</bold>
</xref>). AKK treatment significantly attenuated the release of neuroinflammatory cytokines. In summary, AKK treatment substantially mitigated neuronal damage and neuroinflammation in traumatized mice.</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>AKK treatment improves nerve damage and neuroinflammation in trauma-exposed mice. <bold>(A)</bold> HE staining of the hippocampus, with orange arrows indicating neuronal disturbances and red arrows showing alterations. HP, hippocampus; CA1, cornu ammonis 1; CA3, cornu ammonis 3; DG, dentate gyrus. HP scale: 200 &#xb5;m; DG, CA1, CA3 scale: 50 &#xb5;m. <bold>(B)</bold> Relative expression levels of cytokines (<italic>Il1&#x3b2;</italic>, <italic>Il6</italic>, <italic>Il10</italic>, <italic>Il12</italic>, <italic>Tnf&#x3b1;</italic>, and <italic>Tgf&#x3b2;</italic>) and TNF-&#x3b1; mRNA in the mouse hippocampus, n = 6, **<italic>P</italic>&lt;0.01, ***<italic>P</italic>&lt;0.001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1657524-g007.tif">
<alt-text content-type="machine-generated">Panel A shows hippocampal histology in control, trauma, Trauma+P, and Trauma+A groups, with regions HP, CA1, CA3, and DG highlighted. Panel B presents bar graphs of relative expression levels of inflammatory markers Il1&#x3b2;, Il6, Il10, Il12, Tnfa, and Tgf&#x3b2; across the same groups, with significance denoted by asterisks.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_9">
<title>AKK treatment inhibits microglial activation and enhances the BDNF/TrkB signaling pathway</title>
<p>Microbiota-derived metabolites, including SCFAs and neurotransmitters (e.g., neurotrophic factors, serotonin), can modulate neuroinflammation and microglial function by influencing blood-brain barrier permeability. To investigate the mechanisms by which AKK ameliorates neuroinflammation and cognitive impairments in traumatized mice, immunofluorescence staining for microglial marker IBA1 and BDNF was performed in the hippocampus (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8A</bold>
</xref>). In control mice, microglia exhibited a highly branched structure with three to four branches. Conversely, traumatized mice displayed enlarged microglial cell bodies with shorter and fewer branches. Quantitative analysis of IBA1 fluorescence intensity revealed a significant increase in IBA1-positive staining in the hippocampus of traumatized mice, indicating microglial activation, which was notably reduced following AKK treatment (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8B</bold>
</xref>). Additionally, BDNF fluorescence intensity was decreased in traumatized mice, an effect reversed by AKK treatment (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8C</bold>
</xref>). Western blot analysis further demonstrated that AKK treatment significantly reduced IBA1 expression in traumatized mice (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8D</bold>
</xref>). Furthermore, traumatized mice exhibited significant reductions in BDNF and phosphorylated Tropomyosin Receptor Kinase B (pTrkB) protein levels (<italic>P</italic>&lt;0.05). Additionally, the levels of their downstream molecules pCREB and pERK were also significantly decreased (<italic>P</italic>&lt;0.01). These reductions were restored by AKK treatment, while total TrkB, ERK, and CREB proteins remained unchanged (<italic>P</italic> &gt; 0.05, <xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8E</bold>
</xref>). These findings suggest that AKK treatment inhibits microglial overactivation and promotes the BDNF/TrkB signaling pathway in the hippocampus of traumatized mice.</p>
<fig id="f8" position="float">
<label>Figure&#xa0;8</label>
<caption>
<p>AKK treatment inhibits microglial activation and enhances the BDNF/TrkB signaling pathway. <bold>(A)</bold> Immunofluorescence staining of IBA1 and BDNF in the mouse hippocampus, with red indicating BDNF, green indicating IBA1, and blue indicating DAPI. Scale = 30 &#xb5;m. <bold>(B)</bold> Quantification of IBA1 immunofluorescence, n = 6. <bold>(C)</bold> Quantification of BDNF immunofluorescence, n = 6. <bold>(D)</bold> Western blot analysis of hippocampal proteins. <bold>(E)</bold> Statistical analysis of Western blot results, n = 3, *<italic>P</italic>&lt;0.05, **<italic>P</italic>&lt;0.01.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1657524-g008.tif">
<alt-text content-type="machine-generated">A multi-panel image depicts experimental data on brain tissue. Panel A shows fluorescent microscopy images of brain sections stained for BDNF (red), IBA-1 (green), and DAPI (blue) under four conditions: Control, Trauma, Trauma+P, and Trauma+A. Panels B and C are bar graphs showing relative fluorescence intensity for IBA-1 and BDNF across the same conditions, indicating significant differences. Panel D displays Western blot images for IBA1, BDNF, and other proteins. Panel E presents bar graphs with relative grayscale values for protein expression analysis. Significance is indicated with asterisks.</alt-text>
</graphic>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>This study examined the therapeutic effects of AKK on cognitive impairments and neuroinflammation in a mouse model of blunt chest trauma. The results demonstrate that AKK treatment significantly ameliorated cognitive deficits and anxiety-like behaviors, while also reducing neuroinflammation in the hippocampus (<xref ref-type="fig" rid="f9">
<bold>Figure&#xa0;9</bold>
</xref>).</p>
<fig id="f9" position="float">
<label>Figure&#xa0;9</label>
<caption>
<p>Hypothetical Mechanism of Trauma-Induced Cognitive Dysfunction Modulation by AKK in Mice. Supplementation with Akkermansia muciniphila (AKK) bacteria ameliorates trauma-induced cognitive dysfunction in mice <italic>via</italic> the microbiota-gut-brain axis. Specifically, AKK treatment enhances intestinal microbial homeostasis and metabolite production in traumatized mice. Through the production of short-chain fatty acids (SCFAs) and neuroactive substances, AKK inhibits the overactivation of microglia in the hippocampus. Furthermore, AKK improves cognitive function in mice by activating the BDNF/TrkB signaling pathway.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1657524-g009.tif">
<alt-text content-type="machine-generated">Diagram illustrating the microbiota-gut-brain axis. A mouse is shown with arrows indicating effects of stress and administration of A. muciniphila. Gut microbiota diversity affects the production of SCFAs and neuroactive metabolites, influencing neuroinflammation, activated microglia, and inflammatory cytokines, which in turn affect cognitive function. BDNF and cognitive function are shown to increase.</alt-text>
</graphic>
</fig>
<p>Blunt chest trauma is a common consequence of motor vehicle accidents and falls from heights, often leading to severe pain and respiratory distress, which can result in systemic hemodynamic instability, including hypotension and shock. These conditions can further exacerbate cerebral ischemia and hypoxia, contributing to cognitive impairments. During the acute phase, patients with blunt chest trauma often experience restricted mobility, decreased sleep quality, poor appetite, and heightened psychological stress, all of which can negatively affect cognitive function, manifesting as memory decline, inattention, and executive dysfunction (<xref ref-type="bibr" rid="B34">34</xref>). While most patients show some recovery in cognitive function after the acute phase, a subset may continue to experience long-term cognitive deficits (<xref ref-type="bibr" rid="B35">35</xref>). Our investigation revealed that employing a 300mm drop height in conjunction with a 50g weight successfully established a blunt chest trauma mouse model, which exhibited a 69% survival rate. The histological alterations detected in the pulmonary and cardiac tissues of the experimental mice corroborate the model&#x2019;s capacity to emulate the quintessential pathological hallmarks of blunt chest trauma, including pulmonary hemorrhage, pulmonary edema, and myocardial injury. These findings are in alignment with prior research, which demonstrated that utilizing a 44-mm drop height along with weights of 138g, 190g, and 241g could generate an impact energy ranging from 0.13 to 0.23 J. This setup resulted in indentation depths of 12.4 to 14.7mm and rebound amplitudes of 0.6 to 1mm in mouse cadavers, without inducing rib fractures or dislocations, as evidenced by representative X-rays. Conversely, augmenting the drop height and weight can precipitate substantial intrathoracic hemorrhage, perforation or rupture of the right atrium, and lacerations in the lung lobes, frequently culminating in immediate mortality (<xref ref-type="bibr" rid="B26">26</xref>). The transient respiratory depression experienced by the surviving mice, followed by a gradual recovery of behavioral activity, indicates that this model is well-suited for examining the temporal dynamics of physiological and behavioral responses to trauma.</p>
<p>Behavioral tests in this study revealed that mice with blunt chest trauma exhibited significant reductions in exploration times and distances in the inner area of the OFT and decreased exploration frequencies and preference indices for novel objects in the NORT starting from day 14 post-trauma. These findings align with previous studies demonstrating that blunt chest trauma induces cognitive and emotional impairments in mice (<xref ref-type="bibr" rid="B36">36</xref>). The post-traumatic response is complex and may involve alterations in multiple neurotransmitter systems and neural circuits. Our findings suggest that the trauma model may primarily activate anxiety-related neural circuits, leading to the observed anxiety-like behaviors in the OFT and EPM. In contrast, the lack of significant depressive phenotypes in the TST and FST may indicate that the trauma model has a relatively minor impact on the neural circuits associated with depression. This differential impact on neural circuits could explain the observed phenotypic dissociation (<xref ref-type="bibr" rid="B37">37</xref>). Anxiety and depression, although often co-occurring clinically, involve distinct neural circuits. Anxiety is primarily associated with functional abnormalities in brain regions such as the amygdala, prefrontal cortex, and hippocampus, while depression is more closely linked to dysfunctions in the prefrontal cortex, nucleus accumbens, and raphe nuclei (<xref ref-type="bibr" rid="B38">38</xref>). Therefore, trauma may differentially impact these distinct neural circuits, leading to the observed phenotypic dissociation between anxiety and depression. This dissociation suggests that the trauma model may predominantly activate neural circuits associated with anxiety, while having a lesser impact on those related to depression. Furthermore, the hemodynamic alterations, neuroreflex responses, and inflammatory processes triggered by blunt chest trauma can lead to gastrointestinal dysfunction (<xref ref-type="bibr" rid="B39">39</xref>). Our analysis of gut microbiota composition revealed significant changes in the relative abundance of Lactobacillus, Bacteroides, and Akkermansia in traumatized mice 14 days post-injury, indicating trauma-induced dysbiosis. Previous research has shown that AKK can modulate gut microbiota and improve cognitive function through the alteration of SCFAs (<xref ref-type="bibr" rid="B32">32</xref>). Thus, whether AKK supplementation could alleviate cognitive and emotional impairments resulting from blunt chest trauma was further investigated.</p>
<p>In this study, AKK treatment significantly improved cognitive performance and reduced anxiety-like behaviors. Specifically, AKK-treated mice exhibited increased exploration times and frequencies in the NORT and Y-maze tests, indicating enhanced learning and memory abilities. Moreover, increased exploration interest in the OFT and EPM suggested reduced anxiety. These results align with the findings of Maftoon et&#xa0;al. (<xref ref-type="bibr" rid="B20">20</xref>). Numerous studies have demonstrated that AKK modulates the microbiota-gut-brain axis and plays a pivotal role in various neurological disorders. AKK regulates gut microbiota composition and metabolites, restores gut mucosal barrier integrity, modulates host immunity and neuroinflammation, and participates in the pathogenesis of neurological diseases (<xref ref-type="bibr" rid="B40">40</xref>). The underlying mechanisms likely involve AKK-derived SCFAs and other metabolites that influence neuroinflammation and neuronal health (<xref ref-type="bibr" rid="B41">41</xref>). 16S rRNA sequencing revealed that AKK treatment altered gut microbiota composition, significantly increasing the abundance of beneficial taxa such as <italic>Lactobacillus</italic> and <italic>Akkermansia</italic>. Non-targeted metabolomics analysis identified 70 differential metabolites in traumatized mice following AKK treatment, which were associated with alanine metabolism, alanine, aspartate, and glutamate metabolism, oxidative phosphorylation, biosynthesis of histidine and purine-derived alkaloids, and other biological processes. Previous studies have established a link between gut microbiota and cognitive impairments (<xref ref-type="bibr" rid="B42">42</xref>). For instance, the AKK-derived outer membrane protein Amuc_1100 can regulate L-arginine metabolism and mitigate age-related cognitive decline (<xref ref-type="bibr" rid="B43">43</xref>). AKK-derived exosomes have been shown to modulate serotonin metabolism in both the gut and hippocampus, preserving gut barrier and blood-brain barrier integrity, inhibiting inflammatory responses, and attenuating microglial TLR2/4 signaling, thereby improving postoperative cognitive dysfunction (<xref ref-type="bibr" rid="B44">44</xref>). <italic>Lactobacillus</italic> treatment has been reported to alleviate oxidative stress and inflammatory responses in high-fat diet-induced rats, improving cognitive function and mitigating neurodegenerative diseases (<xref ref-type="bibr" rid="B45">45</xref>). Furthermore, supplementation with <italic>Lactobacillus rhamnosus GG</italic> has been shown to increase synaptic proteins such as SYN and PSD-95 and BDNF in chronic ethanol-exposed mice, improving neuroinflammation and memory function (<xref ref-type="bibr" rid="B46">46</xref>). These changes in microbiota composition likely contribute to the observed improvements in cognitive and emotional outcomes, underscoring the critical role of gut microbiota homeostasis in maintaining metabolic and immune balance.</p>
<p>Microbiota-regulated metabolites and neurotransmitters can influence CNS inflammatory responses through the gut-brain axis (<xref ref-type="bibr" rid="B11">11</xref>). Neuroinflammation is a key factor in the pathophysiology of cognitive impairments following blunt chest trauma, where chronic inflammation exacerbates learning and memory deficits by affecting neurotransmitters and neural circuits (<xref ref-type="bibr" rid="B47">47</xref>). Elevated inflammatory markers in the serum, prefrontal cortex, and hippocampus of traumatized patients have been shown to impair cognitive function and emotional regulation (<xref ref-type="bibr" rid="B48">48</xref>). Our study demonstrated significant neuronal damage and increased inflammatory cytokine expression in the hippocampus of traumatized mice, consistent with previous findings (<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B22">22</xref>). AKK treatment significantly reduced pro-inflammatory cytokines such as IL-1&#x3b2;, IL-6, and TNF-&#x3b1; while increasing anti-inflammatory markers like IL-10, indicating its neuroprotective effects through modulation of inflammatory responses, in line with findings by Qiao et&#xa0;al. (<xref ref-type="bibr" rid="B49">49</xref>). Microglia, the resident immune cells of the CNS, play a pivotal role in the development and progression of neuroinflammation. Upon detecting pathological signals, microglia become activated and release pro-inflammatory cytokines such as IL-1&#x3b2;, IL-6, and TNF-&#x3b1;, which exacerbate neuroinflammation (<xref ref-type="bibr" rid="B50">50</xref>). Blunt chest trauma triggers the release of inflammatory mediators into the bloodstream, activating microglia in the brain (<xref ref-type="bibr" rid="B51">51</xref>). While activated microglia can clear pathogens and damaged cells, promote synaptic pruning and strengthening, and maintain brain homeostasis (<xref ref-type="bibr" rid="B52">52</xref>), excessive or chronic activation can lead to sustained inflammation, tissue damage, and neurodegeneration (<xref ref-type="bibr" rid="B50">50</xref>). Our results demonstrated that AKK treatment significantly reduced microglial activation in the hippocampus, consistent with previous reports (<xref ref-type="bibr" rid="B53">53</xref>). Additionally, microglia, astrocytes, and other cells secrete BDNF, a key regulator influencing neuronal survival, synaptic plasticity, and neuroinflammation (<xref ref-type="bibr" rid="B54">54</xref>). Immunofluorescence and western blot analyses revealed increased IBA1 (microglial) expression and decreased BDNF expression in the hippocampus of traumatized mice. Studies have shown that BDNF mRNA levels are downregulated in the hippocampus of rats following trauma (<xref ref-type="bibr" rid="B55">55</xref>). Plasma BDNF levels in traumatized patients are significantly lower than in healthy controls, impacting the BDNF/TrkB signaling pathway that regulates synaptic plasticity (<xref ref-type="bibr" rid="B56">56</xref>). Hauck et&#xa0;al. reported that BDNF expression initially increases shortly after trauma but decreases over time (<xref ref-type="bibr" rid="B57">57</xref>). Thus, microglial activation may be linked to the early increase in BDNF (<xref ref-type="bibr" rid="B58">58</xref>). BDNF, a key neurotrophic factor influencing cognitive function, has levels closely associated with cognitive abilities (<xref ref-type="bibr" rid="B59">59</xref>). BDNF binds to its high-affinity receptor TrkB, enhancing TrkB phosphorylation and activating downstream signaling pathways, such as CREB and ERK. These pathways promote neuronal survival and synaptic plasticity, thus regulating neuronal viability and influencing learning and memory functions (<xref ref-type="bibr" rid="B60">60</xref>, <xref ref-type="bibr" rid="B61">61</xref>). Under traumatic stress, BDNF and its receptor TrkB expression vary depending on the duration and type of stress and the affected brain region, leading to neuronal degeneration and contributing to various CNS diseases (<xref ref-type="bibr" rid="B62">62</xref>).</p>
<p>Our study provides evidence that AKK treatment modulates gut microbiota and metabolites, which are associated with improvements in cognitive function and reductions in neuroinflammation following blunt chest trauma. However, there are several limitations to our study. First, the absence of fecal microbiota transplantation (FMT) experiments limits our ability to establish a causal relationship between microbial changes and neurobehavioral outcomes. Second, the lack of comparative analysis with established neuroprotective probiotics, such as Lactobacillus or Bifidobacterium species, restricts our understanding of AKK&#x2019;s relative efficacy and mechanisms of action. Future studies should incorporate FMT and comparative analyses with well-known neuroprotective probiotics to provide a more comprehensive assessment of AKK&#x2019;s therapeutic potential. Additionally, our microbiome and metabolomics analysis was conducted only at day 14 post-trauma, which does not fully capture the dynamic changes over the 60-day period during which behavioral recovery was observed. This temporal disconnect limits our ability to understand the relationship between gut microbiota changes and cognitive recovery patterns. Future studies should consider longitudinal sampling to elucidate the temporal dynamics of gut microbiota and metabolite changes in relation to cognitive recovery following blunt chest trauma (<xref ref-type="bibr" rid="B63">63</xref>, <xref ref-type="bibr" rid="B64">64</xref>).</p>
</sec>
<sec id="s5" sec-type="conclusions">
<title>Conclusions</title>
<p>In conclusion, our findings support the hypothesis that AKK could serve as a next-generation probiotic with the potential to alleviate cognitive impairments and neuroinflammation following trauma. This study emphasizes the critical role of gut microbiota in brain health and suggests that targeting the gut-brain axis may offer novel therapeutic strategies for managing trauma-related cognitive and emotional disturbances. Further research is needed to clarify the precise mechanisms by which AKK influences neuroinflammation and cognitive function and to explore its potential clinical applications in patients with trauma.</p>
</sec>
</body>
<back>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The 16S rRNA data presented in the study are deposited in the NCBI BioProject repository, accession number PRJNA1227250.</p>
</sec>
<sec id="s7" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The animal study was approved by The Animal Experiment Ethics Committee of the Health Science Center of Xi&#x2019;an Jiaotong University. The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec id="s8" sec-type="author-contributions">
<title>Author contributions</title>
<p>LL: Conceptualization, Funding acquisition, Data curation, Writing &#x2013; original draft. LW: Writing &#x2013; review &amp; editing, Writing &#x2013; original draft, Data curation, Conceptualization. YW: Writing &#x2013; original draft, Data curation, Conceptualization. HZ: Data curation, Writing &#x2013; original draft, Formal Analysis. XG: Writing &#x2013; original draft, Data curation, Formal Analysis. WY: Writing &#x2013; review &amp; editing, Methodology. JX: Data curation, Writing &#x2013; review &amp; editing, Methodology.</p>
</sec>
<sec id="s9" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research and/or publication of this article. This work was supported by the Natural Science Basic Research Program of Shaanxi Province (Grant No. 2025JC-YBQN-1089), the Youth Talent Support Program of the Xi&#x2019;an Science and Technology Association (Grant No. 0959202513182).</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>We thank Bullet Edits Limited for the linguistic editing and proofreading of the manuscript. Their professional support has significantly enhanced the quality of expression in the manuscript. We also sincerely thank BioRender for providing the illustrative materials for this study. The graphical abstract was created <italic>via</italic> <ext-link ext-link-type="uri" xlink:href="https://BioRender.com">https://BioRender.com</ext-link>, a platform that boasts a rich library of scientific illustrations, which has greatly enriched the presentation of our research.</p>
</ack>
<sec id="s10" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s11" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec id="s12" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s13" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fimmu.2025.1657524/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fimmu.2025.1657524/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Supplementaryfile1.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
<supplementary-material xlink:href="Supplementaryfile2.docx" id="SM2" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
<supplementary-material xlink:href="Table1.docx" id="ST1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murphy</surname> <given-names>SL</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Kochanek</surname> <given-names>KD</given-names>
</name>
<name>
<surname>Arias</surname> <given-names>E</given-names>
</name>
<name>
<surname>Tejada-Vera</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>Deaths: final data for 2018</article-title>. <source>Natl Vital Stat Rep</source>. (<year>2021</year>) <volume>69</volume>:<fpage>1</fpage>&#x2013;<lpage>83</lpage>.</citation></ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>LoCicero</surname> <given-names>JR</given-names>
</name>
<name>
<surname>Mattox</surname> <given-names>KL</given-names>
</name>
</person-group>. <article-title>Epidemiology of chest trauma</article-title>. <source>Surg Clin North Am</source>. (<year>1989</year>) <volume>69</volume>:<page-range>15&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0039-6109(16)44730-4</pub-id>, PMID: <pub-id pub-id-type="pmid">2911786</pub-id></citation></ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marts</surname> <given-names>B</given-names>
</name>
<name>
<surname>Durham</surname> <given-names>R</given-names>
</name>
<name>
<surname>Shapiro</surname> <given-names>M</given-names>
</name>
<name>
<surname>Mazuski</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Zuckerman</surname> <given-names>D</given-names>
</name>
<name>
<surname>Sundaram</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Computed tomography in the diagnosis of blunt thoracic injury</article-title>. <source>Am J Surg</source>. (<year>1994</year>) <volume>168</volume>:<page-range>688&#x2013;92</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0002-9610(05)80146-1</pub-id>, PMID: <pub-id pub-id-type="pmid">7978020</pub-id></citation></ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blair</surname> <given-names>E</given-names>
</name>
<name>
<surname>Topuzlu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Davis</surname> <given-names>JH</given-names>
</name>
</person-group>. <article-title>Delayed or missed diagnosis in blunt chest trauma</article-title>. <source>J Trauma</source>. (<year>1971</year>) <volume>11</volume>:<page-range>129&#x2013;45</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/00005373-197102000-00005</pub-id>, PMID: <pub-id pub-id-type="pmid">5541039</pub-id></citation></ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dogrul</surname> <given-names>BN</given-names>
</name>
<name>
<surname>Kiliccalan</surname> <given-names>I</given-names>
</name>
<name>
<surname>Asci</surname> <given-names>ES</given-names>
</name>
<name>
<surname>Peker</surname> <given-names>SC</given-names>
</name>
</person-group>. <article-title>Blunt trauma related chest wall and pulmonary injuries: An overview</article-title>. <source>Chin J Traumatol</source>. (<year>2020</year>) <volume>23</volume>:<page-range>125&#x2013;38</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cjtee.2020.04.003</pub-id>, PMID: <pub-id pub-id-type="pmid">32417043</pub-id></citation></ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qamar</surname> <given-names>SR</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Nicolaou</surname> <given-names>S</given-names>
</name>
<name>
<surname>Murray</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>State of the art imaging review of blunt and penetrating cardiac trauma</article-title>. <source>Can Assoc Radiol J</source>. (<year>2020</year>) <volume>71</volume>:<page-range>301&#x2013;12</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/0846537119899200</pub-id>, PMID: <pub-id pub-id-type="pmid">32066272</pub-id></citation></ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duan</surname> <given-names>M</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Feng</surname> <given-names>H</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Targeting brain-peripheral immune responses for secondary brain injury after ischemic and hemorrhagic stroke</article-title>. <source>J Neuroinflamm</source>. (<year>2024</year>) <volume>21</volume>:<fpage>102</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12974-024-03101-y</pub-id>, PMID: <pub-id pub-id-type="pmid">38637850</pub-id></citation></ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baker</surname> <given-names>E</given-names>
</name>
<name>
<surname>Woolley</surname> <given-names>A</given-names>
</name>
<name>
<surname>Xyrichis</surname> <given-names>A</given-names>
</name>
<name>
<surname>Norton</surname> <given-names>C</given-names>
</name>
<name>
<surname>Hopkins</surname> <given-names>P</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>How does the implementation of a patient pathway-based intervention in the acute care of blunt thoracic injury impact on patient outcomes? A systematic review of the literature</article-title>. <source>Injury</source>. (<year>2020</year>) <volume>51</volume>:<page-range>1733&#x2013;43</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.injury.2020.06.002</pub-id>, PMID: <pub-id pub-id-type="pmid">32576379</pub-id></citation></ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carrie</surname> <given-names>C</given-names>
</name>
<name>
<surname>Guemmar</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Cottenceau</surname> <given-names>V</given-names>
</name>
<name>
<surname>de Molliens</surname> <given-names>L</given-names>
</name>
<name>
<surname>Petit</surname> <given-names>L</given-names>
</name>
<name>
<surname>Sztark</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Long-term disability after blunt chest trauma: Don&#x2019;t miss chronic neuropathic pain</article-title>! <source>Injury</source>. (<year>2019</year>) <volume>50</volume>:<page-range>113&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.injury.2018.10.023</pub-id>, PMID: <pub-id pub-id-type="pmid">30392717</pub-id></citation></ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cotoia</surname> <given-names>A</given-names>
</name>
<name>
<surname>Charitos</surname> <given-names>IA</given-names>
</name>
<name>
<surname>Corriero</surname> <given-names>A</given-names>
</name>
<name>
<surname>Tamburrano</surname> <given-names>S</given-names>
</name>
<name>
<surname>Cinnella</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>The role of macronutrients and gut microbiota in neuroinflammation post-traumatic brain injury: A narrative review</article-title>. <source>Nutrients</source>. (<year>2024</year>) <volume>16</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/nu16244359</pub-id>, PMID: <pub-id pub-id-type="pmid">39770985</pub-id></citation></ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Loh</surname> <given-names>JS</given-names>
</name>
<name>
<surname>Mak</surname> <given-names>WQ</given-names>
</name>
<name>
<surname>Tan</surname> <given-names>L</given-names>
</name>
<name>
<surname>Ng</surname> <given-names>CX</given-names>
</name>
<name>
<surname>Chan</surname> <given-names>HH</given-names>
</name>
<name>
<surname>Yeow</surname> <given-names>SH</given-names>
</name>
<etal/>
</person-group>. <article-title>Microbiota-gut-brain axis and its therapeutic applications in neurodegenerative diseases</article-title>. <source>Signal Transduct Target Ther</source>. (<year>2024</year>) <volume>9</volume>:<fpage>37</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41392-024-01743-1</pub-id>, PMID: <pub-id pub-id-type="pmid">38360862</pub-id></citation></ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kolobaric</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Gut microbiome predicts cognitive function and depressive symptoms in late life</article-title>. <source>Mol Psychiatry</source>. (<year>2024</year>) <volume>29</volume>:<page-range>3064&#x2013;75</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41380-024-02551-3</pub-id>, PMID: <pub-id pub-id-type="pmid">38664490</pub-id></citation></ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname> <given-names>DY</given-names>
</name>
<name>
<surname>Shin</surname> <given-names>YJ</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>JK</given-names>
</name>
<name>
<surname>Jang</surname> <given-names>HM</given-names>
</name>
<name>
<surname>Joo</surname> <given-names>MK</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>DH</given-names>
</name>
</person-group>. <article-title>Alleviation of cognitive impairment by gut microbiota lipopolysaccharide production-suppressing Lactobacillus plantarum and Bifidobacterium longum in mice</article-title>. <source>Food Funct</source>. (<year>2021</year>) <volume>12</volume>:<page-range>10750&#x2013;63</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1039/D1FO02167B</pub-id>, PMID: <pub-id pub-id-type="pmid">34608923</pub-id></citation></ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Song</surname> <given-names>YX</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>XD</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>YG</given-names>
</name>
<name>
<surname>Miao</surname> <given-names>R</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>XM</given-names>
</name>
<etal/>
</person-group>. <article-title>Gut microbiota and cognitive performance: A bidirectional two-sample Mendelian randomization</article-title>. <source>J Affect Disord</source>. (<year>2024</year>) <volume>353</volume>:<fpage>38</fpage>&#x2013;<lpage>47</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jad.2024.02.083</pub-id>, PMID: <pub-id pub-id-type="pmid">38417715</pub-id></citation></ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ou</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Deng</surname> <given-names>L</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>F</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Protective effects of Akkermansia muciniphila on cognitive deficits and amyloid pathology in a mouse model of Alzheimer&#x2019;s disease</article-title>. <source>Nutr Diabetes</source>. (<year>2020</year>) <volume>10</volume>:<fpage>12</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41387-020-0115-8</pub-id>, PMID: <pub-id pub-id-type="pmid">32321934</pub-id></citation></ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van der Lugt</surname> <given-names>B</given-names>
</name>
<name>
<surname>van Beek</surname> <given-names>AA</given-names>
</name>
<name>
<surname>Aalvink</surname> <given-names>S</given-names>
</name>
<name>
<surname>Meijer</surname> <given-names>B</given-names>
</name>
<name>
<surname>Sovran</surname> <given-names>B</given-names>
</name>
<name>
<surname>Vermeij</surname> <given-names>WP</given-names>
</name>
<etal/>
</person-group>. <article-title>Akkermansia muciniphila ameliorates the age-related decline in colonic mucus thickness and attenuates immune activation in accelerated aging Ercc1 (-/Delta7) mice</article-title>. <source>Immun Ageing</source>. (<year>2019</year>) <volume>16</volume>:<fpage>6</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12979-019-0145-z</pub-id>, PMID: <pub-id pub-id-type="pmid">30899315</pub-id></citation></ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Qin</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>M</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>X</given-names>
</name>
<name>
<surname>He</surname> <given-names>F</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Akkermansia muciniphila can reduce the damage of gluco/lipotoxicity, oxidative stress and inflammation, and normalize intestine microbiota in streptozotocin-induced diabetic rats</article-title>. <source>Pathog Dis</source>. (<year>2018</year>) <volume>76</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/femspd/fty028</pub-id>, PMID: <pub-id pub-id-type="pmid">29668928</pub-id></citation></ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Higarza</surname> <given-names>SG</given-names>
</name>
<name>
<surname>Arboleya</surname> <given-names>S</given-names>
</name>
<name>
<surname>Arias</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Gueimonde</surname> <given-names>M</given-names>
</name>
<name>
<surname>Arias</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>Akkermansia muciniphila and environmental enrichment reverse cognitive impairment associated with high-fat high-cholesterol consumption in rats</article-title>. <source>Gut Microbes</source>. (<year>2021</year>) <volume>13</volume>:<fpage>1</fpage>&#x2013;<lpage>20</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/19490976.2021.1880240</pub-id>, PMID: <pub-id pub-id-type="pmid">33678110</pub-id></citation></ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname> <given-names>F</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ou</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>D</given-names>
</name>
<name>
<surname>Deng</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>An Akkermansia muciniphila subtype alleviates high-fat diet-induced metabolic disorders and inhibits the neurodegenerative process in mice</article-title>. <source>Anaerobe</source>. (<year>2020</year>) <volume>61</volume>:<fpage>102138</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.anaerobe.2019.102138</pub-id>, PMID: <pub-id pub-id-type="pmid">31830598</pub-id></citation></ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maftoon</surname> <given-names>H</given-names>
</name>
<name>
<surname>Davar</surname> <given-names>SS</given-names>
</name>
<name>
<surname>Tarashi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Soroush</surname> <given-names>E</given-names>
</name>
<name>
<surname>Basir</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Rahimi</surname> <given-names>FA</given-names>
</name>
<etal/>
</person-group>. <article-title>Ameliorative effects of Akkermansia muciniphila on anxiety-like behavior and cognitive deficits in a rat model of Alzheimer&#x2019;s disease</article-title>. <source>Brain Res</source>. (<year>2024</year>) <volume>1845</volume>:<fpage>149280</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.brainres.2024.149280</pub-id>, PMID: <pub-id pub-id-type="pmid">39419309</pub-id></citation></ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname> <given-names>K</given-names>
</name>
<name>
<surname>An</surname> <given-names>F</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>D</given-names>
</name>
<name>
<surname>Li</surname> <given-names>T</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Akkermansia muciniphila: A potential target for the prevention of diabetes</article-title>. <source>Foods</source>. (<year>2024</year>) <volume>14</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/foods14010023</pub-id>, PMID: <pub-id pub-id-type="pmid">39796314</pub-id></citation></ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Du</surname> <given-names>Y</given-names>
</name>
<name>
<surname>An</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Song</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Li</surname> <given-names>N</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>J</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Live and pasteurized Akkermansia muciniphila ameliorates diabetic cognitive impairment by modulating gut microbiota and metabolites in db/db mice</article-title>. <source>Exp Neurol</source>. (<year>2024</year>) <volume>378</volume>:<fpage>114823</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.expneurol.2024.114823</pub-id>, PMID: <pub-id pub-id-type="pmid">38782351</pub-id></citation></ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nadkarni</surname> <given-names>S</given-names>
</name>
<name>
<surname>McArthur</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>estrogen and immunomodulation: new mechanisms that impact on peripheral and central immunity</article-title>. <source>Curr Opin Pharmacol</source>. (<year>2013</year>) <volume>13</volume>:<page-range>576&#x2013;81</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.coph.2013.05.007</pub-id>, PMID: <pub-id pub-id-type="pmid">23731522</pub-id></citation></ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hernandez-Bello</surname> <given-names>R</given-names>
</name>
<name>
<surname>Nava-Castro</surname> <given-names>K</given-names>
</name>
<name>
<surname>Muniz-Hernandez</surname> <given-names>S</given-names>
</name>
<name>
<surname>Nava-Luna</surname> <given-names>P</given-names>
</name>
<name>
<surname>Trejo-Sanchez</surname> <given-names>I</given-names>
</name>
<name>
<surname>Tiempos-Guzman</surname> <given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>Beyond the reproductive effect of sex steroids: their role during immunity to helminth parasite infections</article-title>. <source>Mini Rev Med Chem</source>. (<year>2012</year>) <volume>12</volume>:<page-range>1071&#x2013;80</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2174/138955712802762149</pub-id>, PMID: <pub-id pub-id-type="pmid">22924485</pub-id></citation></ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fitschen-Oestern</surname> <given-names>S</given-names>
</name>
<name>
<surname>Lippross</surname> <given-names>S</given-names>
</name>
<name>
<surname>Klueter</surname> <given-names>T</given-names>
</name>
<name>
<surname>Weuster</surname> <given-names>M</given-names>
</name>
<name>
<surname>Varoga</surname> <given-names>D</given-names>
</name>
<name>
<surname>Tohidnezhad</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Correction to: A new multiple trauma model of the mouse</article-title>. <source>BMC Musculoskelet Disord</source>. (<year>2019</year>) <volume>20</volume>:<fpage>72</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12891-018-2330-1</pub-id>, PMID: <pub-id pub-id-type="pmid">30744619</pub-id></citation></ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hofer</surname> <given-names>D</given-names>
</name>
<name>
<surname>Korbel</surname> <given-names>C</given-names>
</name>
<name>
<surname>Laschke</surname> <given-names>MW</given-names>
</name>
<name>
<surname>Veith</surname> <given-names>NT</given-names>
</name>
<name>
<surname>Pohlemann</surname> <given-names>T</given-names>
</name>
<name>
<surname>Kappl</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Experimental induction of blunt chest trauma in mice: A modified approach with evaluation in dummies and cadavers</article-title>. <source>Exp Ther Med</source>. (<year>2020</year>) <volume>20</volume>:<fpage>28</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3892/etm.2020.9156</pub-id>, PMID: <pub-id pub-id-type="pmid">32952619</pub-id></citation></ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Foley</surname> <given-names>PL</given-names>
</name>
<name>
<surname>Kendall</surname> <given-names>LV</given-names>
</name>
<name>
<surname>Turner</surname> <given-names>PV</given-names>
</name>
</person-group>. <article-title>Clinical management of pain in rodents</article-title>. <source>Comp Med</source>. (<year>2019</year>) <volume>69</volume>:<page-range>468&#x2013;89</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.30802/AALAS-CM-19-000048</pub-id>, PMID: <pub-id pub-id-type="pmid">31822323</pub-id></citation></ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>R</given-names>
</name>
<name>
<surname>Li</surname> <given-names>X</given-names>
</name>
<name>
<surname>Shao</surname> <given-names>P</given-names>
</name>
<name>
<surname>Xie</surname> <given-names>J</given-names>
</name>
<name>
<surname>Su</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>Lactobacillus rhamnosus GG improves cognitive impairments in mice with sepsis</article-title>. <source>Peerj</source>. (<year>2024</year>) <volume>12</volume>:<elocation-id>e17427</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.7717/peerj.17427</pub-id>, PMID: <pub-id pub-id-type="pmid">38827289</pub-id></citation></ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xie</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Yin</surname> <given-names>W</given-names>
</name>
<etal/>
</person-group>. <article-title>Exertional heat stroke-induced changes in gut microbiota cause cognitive impairment in mice</article-title>. <source>BMC Microbiol</source>. (<year>2024</year>) <volume>24</volume>:<fpage>134</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12866-024-03276-7</pub-id>, PMID: <pub-id pub-id-type="pmid">38654189</pub-id></citation></ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Xian</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>R</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>C</given-names>
</name>
<name>
<surname>Xie</surname> <given-names>RG</given-names>
</name>
<name>
<surname>Tian</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Brachial plexus avulsion induced changes in gut microbiota promotes pain related anxiety-like behavior in mice</article-title>. <source>Front Neurol</source>. (<year>2023</year>) <volume>14</volume>:<elocation-id>1084494</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fneur.2023.1084494</pub-id>, PMID: <pub-id pub-id-type="pmid">36846129</pub-id></citation></ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>M</given-names>
</name>
<name>
<surname>Yuan</surname> <given-names>C</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>Effect of histone demethylase KDM5B on long-term cognitive impairment in neonatal rats induced by sevoflurane</article-title>. <source>Front Mol Neurosci</source>. (<year>2024</year>) <volume>17</volume>:<elocation-id>1459358</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fnmol.2024.1459358</pub-id>, PMID: <pub-id pub-id-type="pmid">39664113</pub-id></citation></ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>N</given-names>
</name>
<name>
<surname>Tan</surname> <given-names>S</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Deng</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>N</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Akkermansia muciniphila supplementation prevents cognitive impairment in sleep-deprived mice by modulating microglial engulfment of synapses</article-title>. <source>Gut Microbes</source>. (<year>2023</year>) <volume>15</volume>:<fpage>2252764</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/19490976.2023.2252764</pub-id>, PMID: <pub-id pub-id-type="pmid">37671803</pub-id></citation></ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olson</surname> <given-names>CA</given-names>
</name>
<etal/>
</person-group>. <article-title>Alterations in the gut microbiota contribute to cognitive impairment induced by the ketogenic diet and hypoxia</article-title>. <source>Cell Host Microbe</source>. (<year>2021</year>) <volume>29</volume>:<fpage>1378</fpage>&#x2013;<lpage>92.e6</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.chom.2021.07.004</pub-id>, PMID: <pub-id pub-id-type="pmid">34358434</pub-id></citation></ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Unsworth</surname> <given-names>A</given-names>
</name>
<name>
<surname>Curtis</surname> <given-names>K</given-names>
</name>
<name>
<surname>Asha</surname> <given-names>SE</given-names>
</name>
</person-group>. <article-title>Treatments for blunt chest trauma and their impact on patient outcomes and health service delivery</article-title>. <source>Scand J Trauma Resusc Emerg Med</source>. (<year>2015</year>) <volume>23</volume>:<fpage>17</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13049-015-0091-5</pub-id>, PMID: <pub-id pub-id-type="pmid">25887859</pub-id></citation></ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prieto</surname> <given-names>S</given-names>
</name>
<name>
<surname>Nolan</surname> <given-names>KE</given-names>
</name>
<name>
<surname>Moody</surname> <given-names>JN</given-names>
</name>
<name>
<surname>Hayes</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Hayes</surname> <given-names>JP</given-names>
</name>
</person-group>. <article-title>Posttraumatic stress symptom severity predicts cognitive decline beyond the effect of Alzheimer&#x2019;s disease biomarkers in Veterans</article-title>. <source>Transl Psychiatry</source>. (<year>2023</year>) <volume>13</volume>:<fpage>102</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41398-023-02354-0</pub-id>, PMID: <pub-id pub-id-type="pmid">36990983</pub-id></citation></ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kong</surname> <given-names>CH</given-names>
</name>
<name>
<surname>Min</surname> <given-names>HS</given-names>
</name>
<name>
<surname>Jeon</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kang</surname> <given-names>WC</given-names>
</name>
<name>
<surname>Park</surname> <given-names>K</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>MS</given-names>
</name>
<etal/>
</person-group>. <article-title>Cheonwangbosimdan mitigates post-traumatic stress disorder-like behaviors through GluN2B-containing NMDA receptor antagonism in mice</article-title>. <source>J Ethnopharmacol</source>. (<year>2024</year>) <volume>330</volume>:<fpage>118270</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jep.2024.118270</pub-id>, PMID: <pub-id pub-id-type="pmid">38685368</pub-id></citation></ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iqbal</surname> <given-names>J</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>GD</given-names>
</name>
<name>
<surname>Xue</surname> <given-names>YX</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>M</given-names>
</name>
<name>
<surname>Jia</surname> <given-names>XJ</given-names>
</name>
</person-group>. <article-title>The neural circuits and molecular mechanisms underlying fear dysregulation in posttraumatic stress disorder</article-title>. <source>Front Neurosci</source>. (<year>2023</year>) <volume>17</volume>:<elocation-id>1281401</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fnins.2023.1281401</pub-id>, PMID: <pub-id pub-id-type="pmid">38116070</pub-id></citation></ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Treadway</surname> <given-names>MT</given-names>
</name>
<name>
<surname>Zald</surname> <given-names>DH</given-names>
</name>
</person-group>. <article-title>Reconsidering anhedonia in depression: lessons from translational neuroscience</article-title>. <source>Neurosci Biobehav Rev</source>. (<year>2011</year>) <volume>35</volume>:<page-range>537&#x2013;55</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.neubiorev.2010.06.006</pub-id>, PMID: <pub-id pub-id-type="pmid">20603146</pub-id></citation></ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hughes</surname> <given-names>RK</given-names>
</name>
</person-group>. <article-title>Thoracic trauma</article-title>. <source>Surg Clin North Am</source>. (<year>1968</year>) <volume>48</volume>:<page-range>759&#x2013;71</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0039-6109(16)38579-6</pub-id>, PMID: <pub-id pub-id-type="pmid">4877855</pub-id></citation></ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lei</surname> <given-names>W</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>J</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Shao</surname> <given-names>L</given-names>
</name>
<name>
<surname>Kong</surname> <given-names>Q</given-names>
</name>
<etal/>
</person-group>. <article-title>Akkermansia muciniphila in neuropsychiatric disorders: friend or foe</article-title>? <source>Front Cell Infect Microbiol</source>. (<year>2023</year>) <volume>13</volume>:<elocation-id>1224155</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2023.1224155</pub-id>, PMID: <pub-id pub-id-type="pmid">37492530</pub-id></citation></ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barbalho</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Leme</surname> <given-names>BB</given-names>
</name>
<name>
<surname>Da</surname> <given-names>SCOJ</given-names>
</name>
<name>
<surname>Patocka</surname> <given-names>J</given-names>
</name>
<name>
<surname>Barbalho</surname> <given-names>LC</given-names>
</name>
<name>
<surname>Tanaka</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Molecular mechanisms underlying neuroinflammation intervention with medicinal plants: A critical and narrative review of the current literature</article-title>. <source>Pharm (Basel)</source>. (<year>2025</year>) <volume>18</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ph18010133</pub-id>, PMID: <pub-id pub-id-type="pmid">39861194</pub-id></citation></ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname> <given-names>J</given-names>
</name>
<name>
<surname>Hou</surname> <given-names>T</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>L-arginine metabolism ameliorates age-related cognitive impairment by Amuc_1100-mediated gut homeostasis maintaining</article-title>. <source>Aging Cell</source>. (<year>2024</year>) <volume>23</volume>:<elocation-id>e14081</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/acel.14081</pub-id>, PMID: <pub-id pub-id-type="pmid">38236004</pub-id></citation></ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yaghoubfar</surname> <given-names>R</given-names>
</name>
<name>
<surname>Behrouzi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ashrafian</surname> <given-names>F</given-names>
</name>
<name>
<surname>Shahryari</surname> <given-names>A</given-names>
</name>
<name>
<surname>Moradi</surname> <given-names>HR</given-names>
</name>
<name>
<surname>Choopani</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Modulation of serotonin signaling/metabolism by Akkermansia muciniphila and its extracellular vesicles through the gut-brain axis in mice</article-title>. <source>Sci Rep</source>. (<year>2020</year>) <volume>10</volume>:<fpage>22119</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-020-79171-8</pub-id>, PMID: <pub-id pub-id-type="pmid">33335202</pub-id></citation></ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname> <given-names>X</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>C</given-names>
</name>
<name>
<surname>Feng</surname> <given-names>Y</given-names>
</name>
<name>
<surname>You</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Jin</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Li</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Akkermansia muciniphila-derived small extracellular vesicles attenuate intestinal ischemia-reperfusion-induced postoperative cognitive dysfunction by suppressing microglia activation <italic>via</italic> the TLR2/4 signaling</article-title>. <source>Biochim Biophys Acta Mol Cell Res</source>. (<year>2024</year>) <volume>1871</volume>:<fpage>119630</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bbamcr.2023.119630</pub-id>, PMID: <pub-id pub-id-type="pmid">37967793</pub-id></citation></ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shahin</surname> <given-names>NN</given-names>
</name>
<name>
<surname>Ahmed-Farid</surname> <given-names>OA</given-names>
</name>
<name>
<surname>Sakr</surname> <given-names>E</given-names>
</name>
<name>
<surname>Kamel</surname> <given-names>EA</given-names>
</name>
<name>
<surname>Mohamed</surname> <given-names>MM</given-names>
</name>
</person-group>. <article-title>Oral Supplements of Combined Lactobacillus plantarum and Asparagus officinalis Modulate Gut Microbiota and Alleviate High-Fat Diet-Induced Cognitive Deficits and Neurodegeneration in Rats</article-title>. <source>Probiotics Antimicrob Proteins</source>. (<year>2025</year>). doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12602-024-10429-7</pub-id>, PMID: <pub-id pub-id-type="pmid">39777720</pub-id></citation></ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pan</surname> <given-names>X</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>A</given-names>
</name>
<name>
<surname>Guan</surname> <given-names>K</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>C</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Lactobacillus rhamnosus GG attenuates depression-like behavior and cognitive deficits in chronic ethanol exposure mice by down-regulating systemic inflammatory factors</article-title>. <source>Addict Biol</source>. (<year>2024</year>) <volume>29</volume>:<elocation-id>e13445</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/adb.13445</pub-id>, PMID: <pub-id pub-id-type="pmid">39585236</pub-id></citation></ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quinones</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Gallegos</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>FV</given-names>
</name>
<name>
<surname>Heffner</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Dysregulation of inflammation, neurobiology, and cognitive function in PTSD: an integrative review</article-title>. <source>Cognit Affect Behav Neurosci</source>. (<year>2020</year>) <volume>20</volume>:<page-range>455&#x2013;80</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3758/s13415-020-00782-9</pub-id>, PMID: <pub-id pub-id-type="pmid">32170605</pub-id></citation></ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname> <given-names>DH</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>JY</given-names>
</name>
<name>
<surname>Hong</surname> <given-names>DY</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>EC</given-names>
</name>
<name>
<surname>Park</surname> <given-names>SW</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>MR</given-names>
</name>
<etal/>
</person-group>. <article-title>Neuroinflammation in post-traumatic stress disorder</article-title>. <source>Biomedicines</source>. (<year>2022</year>) <volume>10</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/biomedicines10050953</pub-id>, PMID: <pub-id pub-id-type="pmid">35625690</pub-id></citation></ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qiao</surname> <given-names>CM</given-names>
</name>
<etal/>
</person-group>. <article-title>Akkermansia muciniphila Is Beneficial to a Mouse Model of Parkinson&#x2019;s Disease, via Alleviated Neuroinflammation and Promoted Neurogenesis, with Involvement of SCFAs</article-title>. <source>Brain Sci</source>. (<year>2024</year>) <volume>14</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/brainsci14030238</pub-id>, PMID: <pub-id pub-id-type="pmid">38539626</pub-id></citation></ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname> <given-names>C</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Tan</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets</article-title>. <source>Signal Transduct Target Ther</source>. (<year>2023</year>) <volume>8</volume>:<fpage>359</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41392-023-01588-0</pub-id>, PMID: <pub-id pub-id-type="pmid">37735487</pub-id></citation></ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamada</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ohsawa</surname> <given-names>K</given-names>
</name>
<name>
<surname>Imai</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Kohsaka</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kamitori</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>X-ray structures of the microglia/macrophage-specific protein Iba1 from human and mouse demonstrate novel molecular conformation change induced by calcium binding</article-title>. <source>J Mol Biol</source>. (<year>2006</year>) <volume>364</volume>:<page-range>449&#x2013;57</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jmb.2006.09.027</pub-id>, PMID: <pub-id pub-id-type="pmid">17011575</pub-id></citation></ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Butovsky</surname> <given-names>O</given-names>
</name>
<name>
<surname>Weiner</surname> <given-names>HL</given-names>
</name>
</person-group>. <article-title>Microglial signatures and their role in health and disease</article-title>. <source>Nat Rev Neurosci</source>. (<year>2018</year>) <volume>19</volume>:<page-range>622&#x2013;35</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41583-018-0057-5</pub-id>, PMID: <pub-id pub-id-type="pmid">30206328</pub-id></citation></ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>Intestinal Akkermansia muciniphila is beneficial to functional recovery following ischemic stroke</article-title>. <source>J Neuroimmune Pharmacol</source>. (<year>2024</year>) <volume>19</volume>:<fpage>43</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s11481-024-10146-6</pub-id>, PMID: <pub-id pub-id-type="pmid">39141019</pub-id></citation></ref>
<ref id="B54">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coull</surname> <given-names>JA</given-names>
</name>
<etal/>
</person-group>. <article-title>BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain</article-title>. <source>Nature</source>. (<year>2005</year>) <volume>438</volume>:<page-range>1017&#x2013;21</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nature04223</pub-id>, PMID: <pub-id pub-id-type="pmid">16355225</pub-id></citation></ref>
<ref id="B55">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rasmusson</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>L</given-names>
</name>
<name>
<surname>Duman</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Downregulation of BDNF mRNA in the hippocampal dentate gyrus after re-exposure to cues previously associated with footshock</article-title>. <source>Neuropsychopharmacol</source>. (<year>2002</year>) <volume>27</volume>:<page-range>133&#x2013;42</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0893-133X(02)00286-5</pub-id>, PMID: <pub-id pub-id-type="pmid">12093587</pub-id></citation></ref>
<ref id="B56">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dell&#x2019;Osso</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Brain-derived neurotrophic factor plasma levels in patients suffering from post-traumatic stress disorder</article-title>. <source>Prog Neuropsychopharmacol Biol Psychiatry</source>. (<year>2009</year>) <volume>33</volume>:<fpage>899</fpage>&#x2013;<lpage>902</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.pnpbp.2009.04.018</pub-id>, PMID: <pub-id pub-id-type="pmid">19409951</pub-id></citation></ref>
<ref id="B57">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hauck</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Serum brain-derived neurotrophic factor in patients with trauma psychopathology</article-title>. <source>Prog Neuropsychopharmacol Biol Psychiatry</source>. (<year>2010</year>) <volume>34</volume>:<page-range>459&#x2013;62</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.pnpbp.2010.01.010</pub-id>, PMID: <pub-id pub-id-type="pmid">20097247</pub-id></citation></ref>
<ref id="B58">
<label>58</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>W</given-names>
</name>
<etal/>
</person-group>. <article-title>Microglial repopulation reverses cognitive and synaptic deficits in an Alzheimer&#x2019;s disease model by restoring BDNF signaling</article-title>. <source>Brain Behav Immun</source>. (<year>2023</year>) <volume>113</volume>:<page-range>275&#x2013;88</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bbi.2023.07.011</pub-id>, PMID: <pub-id pub-id-type="pmid">37482204</pub-id></citation></ref>
<ref id="B59">
<label>59</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Post</surname> <given-names>RM</given-names>
</name>
</person-group>. <article-title>Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications</article-title>. <source>J Psychiatr Res</source>. (<year>2007</year>) <volume>41</volume>:<page-range>979&#x2013;90</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jpsychires.2006.09.009</pub-id>, PMID: <pub-id pub-id-type="pmid">17239400</pub-id></citation></ref>
<ref id="B60">
<label>60</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>TrkB/BDNF signaling pathway and its small molecular agonists in CNS injury</article-title>. <source>Life Sci</source>. (<year>2024</year>) <volume>336</volume>:<fpage>122282</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.lfs.2023.122282</pub-id>, PMID: <pub-id pub-id-type="pmid">38008209</pub-id></citation></ref>
<ref id="B61">
<label>61</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cappoli</surname> <given-names>N</given-names>
</name>
<name>
<surname>Tabolacci</surname> <given-names>E</given-names>
</name>
<name>
<surname>Aceto</surname> <given-names>P</given-names>
</name>
<name>
<surname>Dello</surname> <given-names>RC</given-names>
</name>
</person-group>. <article-title>The emerging role of the BDNF-TrkB signaling pathway in the modulation of pain perception</article-title>. <source>J Neuroimmunol</source>. (<year>2020</year>) <volume>349</volume>:<fpage>577406</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jneuroim.2020.577406</pub-id>, PMID: <pub-id pub-id-type="pmid">33002723</pub-id></citation></ref>
<ref id="B62">
<label>62</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ginsberg</surname> <given-names>SD</given-names>
</name>
<etal/>
</person-group>. <article-title>Brain-derived neurotrophic factor (BDNF) and TrkB hippocampal gene expression are putative predictors of neuritic plaque and neurofibrillary tangle pathology</article-title>. <source>Neurobiol Dis</source>. (<year>2019</year>) <volume>132</volume>:<fpage>104540</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.nbd.2019.104540</pub-id>, PMID: <pub-id pub-id-type="pmid">31349032</pub-id></citation></ref>
<ref id="B63">
<label>63</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fine</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>John Snow&#x2019;s legacy: epidemiology without borders</article-title>. <source>Lancet</source>. (<year>2013</year>) <volume>381</volume>:<page-range>1302&#x2013;11</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0140-6736(13)60771-0</pub-id>, PMID: <pub-id pub-id-type="pmid">23582396</pub-id></citation></ref>
<ref id="B64">
<label>64</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cetin</surname> <given-names>M</given-names>
</name>
<name>
<surname>Aktas</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Vural</surname> <given-names>I</given-names>
</name>
<name>
<surname>Ozturk</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Salmon calcitonin-loaded Eudragit(R) and Eudragit(R)-PLGA nanoparticles: <italic>in vitro</italic> and <italic>in vivo</italic> evaluation</article-title>. <source>J Microencapsul</source>. (<year>2012</year>) <volume>29</volume>:<page-range>156&#x2013;66</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3109/02652048.2011.635426</pub-id>, PMID: <pub-id pub-id-type="pmid">22126314</pub-id></citation></ref>
</ref-list>
<glossary>
<title>Glossary</title>
<def-list>
<def-item>
<term>AKK</term>
<def>
<p>Akkermansia muciniphila</p>
</def>
</def-item>
<def-item>
<term>BDNF</term>
<def>
<p>Brain-derived neurotrophic factor</p>
</def>
</def-item>
<def-item>
<term>CA</term>
<def>
<p>Cornu Ammonis</p>
</def>
</def-item>
<def-item>
<term>CNS</term>
<def>
<p>Central nervous system</p>
</def>
</def-item>
<def-item>
<term>DG</term>
<def>
<p>Dentate gyrus</p>
</def>
</def-item>
<def-item>
<term>EPM</term>
<def>
<p>Elevated plus maze</p>
</def>
</def-item>
<def-item>
<term>FST</term>
<def>
<p>Forced swimming test</p>
</def>
</def-item>
<def-item>
<term>HE</term>
<def>
<p>Hematoxylin-eosin</p>
</def>
</def-item>
<def-item>
<term>IBA1</term>
<def>
<p>Ionized calcium-binding adapter molecule 1</p>
</def>
</def-item>
<def-item>
<term>IF</term>
<def>
<p>Immunofluorescence</p>
</def>
</def-item>
<def-item>
<term>KEGG</term>
<def>
<p>Kyoto Encyclopedia of Genes and Genomes</p>
</def>
</def-item>
<def-item>
<term>NORT</term>
<def>
<p>Novel object recognition test</p>
</def>
</def-item>
<def-item>
<term>OFT</term>
<def>
<p>Open field test</p>
</def>
</def-item>
<def-item>
<term>PBS</term>
<def>
<p>Phosphate-buffered saline</p>
</def>
</def-item>
<def-item>
<term>PD</term>
<def>
<p>Parkinson&#x2019;s disease</p>
</def>
</def-item>
<def-item>
<term>PE</term>
<def>
<p>Positive electrospray ionization</p>
</def>
</def-item>
<def-item>
<term>PI3K/mTOR</term>
<def>
<p>Phosphatidylinositol 3-kinase/mammalian target of rapamycin</p>
</def>
</def-item>
<def-item>
<term>qPCR</term>
<def>
<p>Quantitative real-time polymerase chain reaction</p>
</def>
</def-item>
<def-item>
<term>RDP</term>
<def>
<p>Ribosomal Database Project</p>
</def>
</def-item>
<def-item>
<term>SCFAs</term>
<def>
<p>Short-chain fatty acids</p>
</def>
</def-item>
<def-item>
<term>TrkB</term>
<def>
<p>Tropomyosin receptor kinase B</p>
</def>
</def-item>
</def-list>
</glossary>
</back>
</article>